Therefore, the induction of ERRFI1 expression in response to GR activation by HNK could be applicable to HCC prevention in patients with chronic liver diseases, especially NASH/NAFLD. Here, NR3C1 is linked to metabolic dysfunction-associated steatotic liver disease.